Tenax Therapeutics (TENX) Other Working Capital Changes (2016 - 2017)
Historic Other Working Capital Changes for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to $212746.0.
- Tenax Therapeutics' Other Working Capital Changes rose 3396.77% to $212746.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$1.1 million, marking a year-over-year decrease of 456481.24%. This contributed to the annual value of -$119393.0 for FY2022, which is 17766.46% down from last year.
- As of Q4 2017, Tenax Therapeutics' Other Working Capital Changes stood at $212746.0, which was up 3396.77% from -$1.2 million recorded in Q3 2017.
- In the past 5 years, Tenax Therapeutics' Other Working Capital Changes ranged from a high of $1.0 million in Q4 2014 and a low of -$1.2 million during Q3 2017
- Its 5-year average for Other Working Capital Changes is -$149065.8, with a median of -$88885.5 in 2015.
- Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 50411.11% in 2013, then crashed by 329065.86% in 2017.
- Over the past 5 years, Tenax Therapeutics' Other Working Capital Changes (Quarter) stood at -$423466.0 in 2013, then soared by 341.52% to $1.0 million in 2014, then crashed by 109.21% to -$94175.0 in 2015, then soared by 268.63% to $158804.0 in 2016, then surged by 33.97% to $212746.0 in 2017.
- Its Other Working Capital Changes was $212746.0 in Q4 2017, compared to -$1.2 million in Q3 2017 and -$63033.0 in Q2 2017.